Published
No. A peptide COA showing 99% purity does not, by itself, prove sterility or establish an endotoxin result. Read the individual analyses listed on the report. If it contains only a purity measurement, the microbiological and endotoxin questions remain unanswered by that document.
The useful next step is to request the missing test information, not to turn a high percentage into a broader safety claim. This guide explains documentation; it does not establish that research material is suitable for human or veterinary use.
Does 99% peptide purity mean sterile?
No. Chemical purity, microbial contamination and bacterial endotoxins are different attributes. FDA’s Q6A pharmaceutical specification guidance addresses sterility, endotoxins/pyrogens and particulate matter as separate items. That separation illustrates why one result cannot stand in for all three. It does not mean a research vial meets pharmaceutical specifications. FDA Q6A: see section 3.3.2.3.
| Reported item | What to check | What it does not supply |
|---|---|---|
| Purity | The method, percentage and laboratory’s reporting definition | An unreported microbial or endotoxin finding |
| Microbiological analysis | The specific test, sample, result and acceptance criteria | An automatic endotoxin result or a guarantee for every vial |
| Bacterial endotoxins | The assay, numerical result, units and reporting limits | A microbial-growth result or an all-contaminants screen |
| Batch relationship | Records connecting the tested sample to the offered lot | A missing test or a result for a different lot |
For the distinction between analytical methods, see HPLC versus mass spectrometry. For what a percentage represents, use purity versus net peptide content.
My peptide report says “sterility: pass.” What should I check?
Read the method before interpreting the heading. For example, Janoshik describes its TAMC/TYMC pass as no microbial colonies detected after cultivation, within its microbiological criteria. Its fail indicates colonies were detected; that analysis alone cannot identify where contamination originated. Preserve that stated scope instead of rewriting a pass as proof that every unit is free of every contaminant. The laboratory’s TAMC/TYMC result definitions.
Do not silently substitute one named microbiological method for another. If a seller cites a particular compendial test, ask for the actual method reference and report. A broad heading and a method identifier are different pieces of information.
FDA’s manufacturing Q&A explains that sterility testing has limitations and forms one part of a wider contamination-control strategy. A passing sample test is therefore different from evidence about manufacturing controls across a batch. This is context from regulated drug manufacturing, not a certification of a research supplier. FDA production and process controls, question 22.
Is an endotoxin test the same as a sterility test?
No. Janoshik describes its endotoxin analysis as an LAL assay measuring lipopolysaccharide, with results reported in EU per vial. It also identifies values below its stated reporting range as estimates. Keep those qualifications and units when recording a finding. A value in EU/vial is not interchangeable with EU/mL. The laboratory’s endotoxin analysis description.
Do not apply an online “safe level” to every peptide vial. FDA’s endotoxin guidance addresses product-specific specifications, sampling and assay conditions; it also explains that sample storage and handling can affect detection. A result needs its applicable context. This article does not calculate human-use limits or translate a research report into an administration decision. FDA pyrogen and endotoxins guidance, Edition 2: questions 1 and 3.
LAL is not the only possible endotoxin method. FDA’s current clarification also discusses recombinant reagents and the need to verify suitability for the tested material. Ask which method was actually used rather than assuming a particular acronym is mandatory on every valid report. FDA clarification on recombinant endotoxin reagents.
My peptide COA has no sterility or endotoxin results. Did it fail?
Missing is not the same as failed. The supplied document does not establish the missing property; it also does not prove that no separate report exists. Ask for the relevant report and verify its relationship to the material.
Write “not reported in the supplied document” until you have checked. Avoid both unsupported conclusions: “it must be fine because purity is high” and “the missing test proves contamination.” A claim such as “third-party tested” still needs a list of the actual analyses.
How can I check the scope of a peptide COA?
This example is invented. It is not a result for Peptide Serum or any supplier. Assume three records describe the same submitted sample of Example Compound X:
- A chemical analysis reports 99.2% purity on its stated basis.
- A TAMC/TYMC record reports a pass under the laboratory’s criteria.
- An endotoxin record labels its finding an estimate below its reporting range.
Someone summarizes these as “99.2% pure, sterile, zero endotoxins.” Which words go beyond the records?
Supported reading: retain the chemical finding and its definition; describe the microbiological pass using the named method’s scope; retain the endotoxin estimate and qualification. “Zero” discards information the laboratory deliberately included. An unqualified sterility guarantee also expands the microbiological result.
Still to check: original report verification, units, sample handling and the relationship to offered stock. Three analyses provide more information than one, but they do not erase those questions or establish suitability for human use.
What should I ask for when a peptide COA only shows purity?
- Exact material and lot: complete name, labeled amount and batch identifier.
- Original reports: laboratory, report number, date and issuer verification route.
- Analyses performed: distinguish purity, content, microbiological and endotoxin results.
- Methods and criteria: the actual test references and the basis for any pass/fail statement.
- Numbers as reported: units, limits, estimates and other qualifications retained.
- Sample relationship: what connects the submitted sample and report to the offered inventory?
Use the COA review worksheet to keep this information together. For a Peptide Serum listing, request available item-specific documentation through Lab Testing. Catalog examples such as BPC-157 5 mg and BPC-157 10 mg require their own supported documentation matches; the product links themselves are not evidence of sterility or endotoxin testing.
Sources checked October 22, 2026. This is a laboratory-documentation guide, not a testing protocol, product certification or human-use safety assessment. Store materials are for in-vitro laboratory research only.